Courtney Phillips
SEC insider (Form 3/4/5 filer). CIK 0001782758. GC and Corp. Secretary at Maze Therapeutics, Inc. (MAZE). 8 reported Form 4/5 transactions since Sep 2024; latest on Sep 3, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Courtney Phillips has filed insider reports for
- Maze Therapeutics, Inc. (MAZE): Officer, GC and Corp. Secretary
Courtney Phillips
CIK: 0001782758
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Maze Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Sep 3, 2026MAZE
Maze Therapeutics, Inc.
SaleDirect22 shares at avg. $25.78$567.16 - Sep 3, 2026MAZE
Maze Therapeutics, Inc.
SaleDirect2K shares at avg. $26.01$52K - Sep 2, 2026MAZE
Maze Therapeutics, Inc.
SaleDirect1.7K shares at avg. $26.38$46K - Sep 2, 2026MAZE
Maze Therapeutics, Inc.
SaleDirect243 shares at avg. $27.12$7K - Sep 1, 2026MAZE
Maze Therapeutics, Inc.
ExerciseDirect11K shares- - Mar 2, 2026MAZE
Maze Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
32K shares- - Mar 2, 2026MAZE
Maze Therapeutics, Inc.
AwardDirectRestricted Stock Units
16K shares- - Sep 22, 2025MAZE
Maze Therapeutics, Inc.
AwardDirectRestricted Stock Units
22K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 3, 2026 | MAZE Maze Therapeutics, Inc. | Sale | 22 | $25.78 | $567 | Direct |
| Sep 3, 2026 | MAZE Maze Therapeutics, Inc. | Sale | 1,990 | $26.01 | $51,766 | Direct |
| Sep 2, 2026 | MAZE Maze Therapeutics, Inc. | Sale | 1,738 | $26.38 | $45,841 | Direct |
| Sep 2, 2026 | MAZE Maze Therapeutics, Inc. | Sale | 243 | $27.12 | $6,590 | Direct |
| Sep 1, 2026 | MAZE Maze Therapeutics, Inc. | Exercise | 11,000 | - | $0 | Direct |
| Mar 2, 2026 | MAZE Maze Therapeutics, Inc. | Award Stock Option (Right to Buy) | 32,000 | - | - | Direct |
| Mar 2, 2026 | MAZE Maze Therapeutics, Inc. | Award Restricted Stock Units | 16,000 | - | - | Direct |
| Sep 22, 2025 | MAZE Maze Therapeutics, Inc. | Award Restricted Stock Units | 22,000 | - | - | Direct |
1-8 of 8 transactions